Experts discuss the safety profile and cost of gene therapy for the management of sickle cell disease.
Jeffrey D. Lebensburger, DO
Advertisement
Articles by Jeffrey D. Lebensburger, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
2
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
3
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
4
Guess the Therapy Answer October 16, 2025
5
